US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.827
- 0.000-0.01%
Trading Nov 7 09:32 ET
211.60MMarket Cap-2298P/E (TTM)
0.827High0.820Low9.50KVolume0.820Open0.828Pre Close7.80KTurnover0.01%Turnover RatioLossP/E (Static)255.75MShares2.05052wk High2.20P/B141.11MFloat Cap0.42052wk Low--Dividend TTM170.55MShs Float21.570Historical High--Div YieldTTM0.89%Amplitude0.420Historical Low0.820Avg Price1Lot Size
Adaptimmune Therapeutics Stock Forum
Sign in to post a comment
$Adaptimmune Therapeutics (ADAP.US)$ .. green when is the pre-market , will drop once open market!!!
1
$Adaptimmune Therapeutics (ADAP.US)$ Item 1.01Entry into a Material Definitive Agreement.
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...
2
2
$Adaptimmune Therapeutics (ADAP.US)$
so the spike in cash is from financing, fyi
so the spike in cash is from financing, fyi
1
20% before didn't TP. will wait patiently... or maybe CL...
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
3
$Adaptimmune Therapeutics (ADAP.US)$
😩. I wish I had more capital. This is about to run hard.
😩. I wish I had more capital. This is about to run hard.
1
$Adaptimmune Therapeutics (ADAP.US)$ HC Wainwright & Co. Reiterates Buy on Adaptimmune Therapeutics, Maintains $4 Price Target
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
hardeep dhaliwal : How’s that stock for long term according to you?